Ingrid Oliver

Ingrid Oliver is an experienced professional in the pharmaceutical industry, currently serving as the Business Unit Director for Oncology & High Specialty at Synthon since February 2024. Prior to this role, Ingrid held the position of Marketing Associate Director for Rare Diseases at PTC Therapeutics, Inc., where responsibilities included start-up readiness. Ingrid's tenure at Biogen encompassed various roles including Sr. Business Unit Manager for Rare Diseases and Sr. Product Manager for Alzheimer Disease and Multiple Sclerosis. Earlier experience includes multiple positions at Amgen, focusing on oncology, hematology, and nephrology, and a marketing internship at Abbott in the immunology sector. Ingrid holds a Professional Certificate in Digital Marketing from Northwestern University's Kellogg School of Management and degrees in Marketing and Public Relations from Universidad Panamericana.